David Kirn, Chief Executive Officer at 4D Molecular Therapeutics, Inc. (FDMT), sold 67,985 shares at $20.93 ($1.4M) on 2023-02-21, disclosed to the SEC on 2023-02-23.
Open-market sale of $1.4M FDMT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.93 | 17,090 | $358K | 25.5% |
| 2 | $20.93 | 17,090 | $358K | 25.5% |
| 3 | $21.49 | 907 | $19K | 1.4% |
| 4 | $20.22 | 16,449 | $333K | 23.8% |
| 5 | $20.22 | 16,449 | $333K | 23.8% |
| Total | $20.59 avg | 67,985 |
| $1.4M |
| 100% |
| Filing → |
| FDMT | SELL | 2026-08-21 | $1.1M | — | Filing → |
| FDMT | SELL | 2026-08-05 | $275K | — | Filing → |
| FDMT | SELL | 2026-08-04 | $125K | — | Filing → |